Evidence map›Paper›PMID 15490103›Full record

ArticleTAG. Theoretical and applied genetics. Theoretische und angewandte Genetik2004

Rpp1, a dominant gene providing race-specific resistance to rose powdery mildew ( Podosphaera pannosa): molecular mapping, SCAR development and confirmation of disease resistance data.

M Linde, L Mattiesch, T Debener

Abstract read
PubMed Publisher
In one paragraph

Article in TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
4.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Recent Progress in Enhancing Fungal Disease Resistance in Ornamental Plants.International journal of molecular sciences · 2021
    Review
  3. Article
  4. Article
  5. Genetic dissection of scent metabolic profiles in diploid rose populations.TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik · 2010
    Article
  6. Powdery mildew resistance in roses: QTL mapping in different environments using selective genotyping.TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik · 2006
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

M LindeFederal Centre for Breeding Research on Cultivated Plants, Institute for Ornamental Plant Breeding, Bornkampsweg 31, 22926 Ahrensburg, Germany. M.Linde@bafz.de.
L Mattiesch
T Debener
Julius Kühn-Institut · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We have previously demonstrated that in the diploid rose population 97/9 resistance to the powdery mildew race 9 is controlled by a major dominant resistance gene, Rpp1. In the study reported here, we isolated several molecular markers closely linked to Rpp1 via bulked segregant analysis, with the gene being tagged in an interval of 5 cM between the two most adjacent markers. It was possible to convert the most closely linked amplified fragment length polymorphic (AFLP) marker into a sequence-characterised amplified region (SCAR) segregating in the same manner. Indirect mapping of Rpp1 in relation to the black spot resistance gene Rdr1 revealed no linkage between the two R genes. Furthermore, the genetic model based on a single dominant resistance gene was supported by the marker data.

Indexed as

Immunity, InnateAscomycotaChromosome MappingChromosomes, PlantDiploidyGenes, DominantGenes, PlantGenetic MarkersPhenotypePlant DiseasesPolymerase Chain ReactionPolymorphism, GeneticRosaGenetic Markers

Identifiers

PMID15490103
OpenAlexW2036119035

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.